These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 25542050

  • 1. Breakpoints for carbapenemase-producing Enterobacteriaceae: is the problem solved?
    Cantón R, Canut A, Morosini MI, Oliver A.
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():33-40. PubMed ID: 25542050
    [Abstract] [Full Text] [Related]

  • 2. [Carbapenem resistance in ESBL positive Enterobacteriaceae isolates causing invasive infections].
    Eser OK, Altun Uludağ H, Ergin A, Boral B, Sener B, Hasçelik G.
    Mikrobiyol Bul; 2014 Jan; 48(1):59-69. PubMed ID: 24506716
    [Abstract] [Full Text] [Related]

  • 3. Comparison of disk diffusion, Etest and VITEK2 for detection of carbapenemase-producing Klebsiella pneumoniae with the EUCAST and CLSI breakpoint systems.
    Vading M, Samuelsen Ø, Haldorsen B, Sundsfjord AS, Giske CG.
    Clin Microbiol Infect; 2011 May; 17(5):668-74. PubMed ID: 20649801
    [Abstract] [Full Text] [Related]

  • 4. Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases.
    Jones RN, Craig WA, Ambrose PG, Dudley MN, Pottumarthy S.
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):235-46. PubMed ID: 16105568
    [Abstract] [Full Text] [Related]

  • 5. Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?
    Oteo J, Miró E, Pérez-Vázquez M, Navarro F.
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():17-23. PubMed ID: 25542048
    [Abstract] [Full Text] [Related]

  • 6. Carbapenemase-producing Enterobacteriaceae: the end of the antibiotic era?
    Pascual Á, Pintado V, Rodríguez-Baño J, Miró JM.
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():1-3. PubMed ID: 25542045
    [Abstract] [Full Text] [Related]

  • 7. Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosis.
    Paño Pardo JR, Serrano Villar S, Ramos Ramos JC, Pintado V.
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():41-8. PubMed ID: 25542051
    [Abstract] [Full Text] [Related]

  • 8. Clinical outcomes of Enterobacteriaceae infections stratified by carbapenem MICs.
    Patel TS, Nagel JL.
    J Clin Microbiol; 2015 Jan; 53(1):201-5. PubMed ID: 25378572
    [Abstract] [Full Text] [Related]

  • 9. Carbapenem-Resistant Enterobacteriaceae Detection Practices in California: What Are We Missing?
    Humphries RM, Hindler JA, Epson E, Horwich-Scholefield S, Miller LG, Mendez J, Martinez JB, Sinkowitz J, Sinkowtiz D, Hershey C, Marquez P, Bhaurla S, Moran M, Pandes L, Terashita D, McKinnell JA.
    Clin Infect Dis; 2018 Mar 19; 66(7):1061-1067. PubMed ID: 29099915
    [Abstract] [Full Text] [Related]

  • 10. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.
    Polsfuss S, Bloemberg GV, Giger J, Meyer V, Hombach M.
    J Antimicrob Chemother; 2012 Jan 19; 67(1):159-66. PubMed ID: 21972269
    [Abstract] [Full Text] [Related]

  • 11. Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study.
    Haldorsen B, Giske CG, Hansen DS, Helgason KO, Kahlmeter G, Löhr IH, Matuschek E, Österblad M, Rantakokko-Jalava K, Wang M, Småbrekke L, Samuelsen Ø, Sundsfjord A, NordicAST CPE Study Group.
    J Antimicrob Chemother; 2018 Oct 01; 73(10):2738-2747. PubMed ID: 30053113
    [Abstract] [Full Text] [Related]

  • 12. What Is the Appropriate Meropenem MIC for Screening of Carbapenemase-Producing Enterobacteriaceae in Low-Prevalence Settings?
    Fattouh R, Tijet N, McGeer A, Poutanen SM, Melano RG, Patel SN.
    Antimicrob Agents Chemother; 2015 Dec 28; 60(3):1556-9. PubMed ID: 26711746
    [Abstract] [Full Text] [Related]

  • 13. Treatment of infections caused by carbapenemase-producing Enterobacteriaceae.
    Rodríguez-Baño J, Cisneros JM, Gudiol C, Martínez JA.
    Enferm Infecc Microbiol Clin; 2014 Dec 28; 32 Suppl 4():49-55. PubMed ID: 25542052
    [Abstract] [Full Text] [Related]

  • 14. Clinical laboratory detection of carbapenem-resistant and carbapenemase-producing Enterobacteriaceae.
    Miller S, Humphries RM.
    Expert Rev Anti Infect Ther; 2016 Aug 28; 14(8):705-17. PubMed ID: 27348447
    [Abstract] [Full Text] [Related]

  • 15. Development of an algorithm for phenotypic screening of carbapenemase-producing Enterobacteriaceae in the routine laboratory.
    Robert J, Pantel A, Merens A, Meiller E, Lavigne JP, Nicolas-Chanoine MH, ONERBA’s carbapenem resistance study group.
    BMC Infect Dis; 2017 Jan 17; 17(1):78. PubMed ID: 28095794
    [Abstract] [Full Text] [Related]

  • 16. Breakpoints for intravenously used cephalosporins in Enterobacteriaceae--EUCAST and CLSI breakpoints.
    Kahlmeter G.
    Clin Microbiol Infect; 2008 Jan 17; 14 Suppl 1():169-74. PubMed ID: 18154542
    [Abstract] [Full Text] [Related]

  • 17. Consequences of revised CLSI and EUCAST guidelines for antibiotic susceptibility patterns of ESBL- and AmpC β-lactamase-producing clinical Enterobacteriaceae isolates.
    Hombach M, Mouttet B, Bloemberg GV.
    J Antimicrob Chemother; 2013 Sep 17; 68(9):2092-8. PubMed ID: 23633681
    [Abstract] [Full Text] [Related]

  • 18. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004).
    Deshpande LM, Jones RN, Fritsche TR, Sader HS.
    Microb Drug Resist; 2006 Sep 17; 12(4):223-30. PubMed ID: 17227206
    [Abstract] [Full Text] [Related]

  • 19. Routinely available antimicrobial susceptibility information can be used to increase the efficiency of screening for carbapenemase-producing Enterobacteriaceae.
    Ong DSY, Altorf-van der Kuil W, Vlek ALM, Schouls LM, Schoffelen AF.
    J Med Microbiol; 2020 Oct 17; 69(10):1235-1239. PubMed ID: 32924918
    [Abstract] [Full Text] [Related]

  • 20. Comparison of antimicrobial pharmacokinetic/pharmacodynamic breakpoints with EUCAST and CLSI clinical breakpoints for Gram-positive bacteria.
    Asín E, Isla A, Canut A, Rodríguez Gascón A.
    Int J Antimicrob Agents; 2012 Oct 17; 40(4):313-22. PubMed ID: 22921422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.